A 51-year-old female presented with axillary-subclavian vein effort throm bosis. The treatment modality was low-dose constant-infusion streptokinase, followed by heparin and coumadin. Near-total resolution of the pathology and symptoms resulted. There were no adverse events secondary to streptokinase.
Get full access to this article
View all access options for this article.
References
1.
Adams JT, DeWeese JA: Effort thrombosis of the axillary and subclavian veins. J Trauma11 (11): 923-926, 1971.
2.
Coon WW, Willis PW: Thrombosis of axillary and subclavian veins. Arch Surg94: 657-660, 1967.
3.
Campbell CB, et al: Axillary, subclavian and brachiocephalic vein obstructions. Surgery82 (6): 816-820, 1977.
4.
Stricker S., et al: Effort thrombosis of the subclavian vein associated with oral contraceptives. Ann Emerg Med10 (11): 596-599, 1981.
5.
Drapanas T., Curran W.: Thrombectomy in the treatment of effort thrombosis of the axillary and subclavian veins. J Trauma6(1): 107-110, 1966.
6.
Rubin RN: The use of thrombolytic therapy in venous thromboembolic disease. Connecticut Med45 (9): 551, 1981.
7.
Sasahara A., et al: Clinical use of thrombolytic agents in venous thromboembolism . Arch Intern Med142: 684-689, 1982.
8.
Tenaka K., Hirst AE, Smith LL: Rate of endothelialization in venous thrombi. Arch Surg117: 1045-1047, 1982.
9.
Bell WR, Meek AG: Guidelines for the use of thrombolytic agents. N Engl J Med301 (23): 1266-1269, 1979 .
10.
Elliott J.: Greater use of fibrinolytic agents urged. JAMA243 (22): 2275-2279, 1980 .
11.
National Institutes of Health Consensus Development ConferenceSummary. Thrombolytic therapy in thrombosis. 3(1), 1980.
12.
Arnesen H., Hoiseth A., Ly B.: Streptokinase of the heparin in the treatment of deep vein thrombosis. Acta Med Scand211: 65-69, 1982.
